Basic Information
Basic information for SNHG11-229-13aa-2
Peptide Name SNHG11-229-13aa-2
Genome Position chr20:38450407-38450445[+]
Species Human
Peptide Sequence MTWGPSSPGGASS
Peptide Length 13
Unique No (SNHG11-201-13aa,SNHG11-202-13aa,SNHG11-203-13aa,SNHG11-205-13aa,SNHG11-206-13aa,SNHG11-207-13aa,SNHG11-209-13aa,SNHG11-211-13aa,SNHG11-212-13aa,SNHG11-214-13aa,SNHG11-215-13aa,SNHG11-217-13aa,SNHG11-218-13aa,SNHG11-219-13aa,SNHG11-220-13aa,SNHG11-221-13aa,SNHG11-222-13aa,SNHG11-223-13aa-3,SNHG11-224-13aa,SNHG11-225-13aa,SNHG11-227-13aa,SNHG11-230-13aa,SNHG11-231-13aa,SNHG11-233-13aa,SNHG11-234-13aa,SNHG11-235-13aa,SNHG11-237-13aa-3)
Grand Average of Hydropathicity -0.4231
Relative Molecular Mass 1437.51
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000174365;SNHG11
Transcript ID/Name ENST00000663763;SNHG11-229
Transcript Length 4108
Coding Ability 0.4056
DNA Sequence Corresponding to Peptide ATGACCTGGGGTCCCAGCTCCCCTGGAGGGGCCTCCTCA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :